Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.61 |
| ▸ | MME | P08473 | 3/20 | 0.60 |
| ▸ | ACE | P12821 | 3/20 | 0.60 |
| ▸ | CPA1 | P15085 | 3/20 | 0.60 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.60 |
| ▸ | MMP2 | P08253 | 8/20 | 0.55 |
| ▸ | MMP1 | P03956 | 8/20 | 0.55 |
| ▸ | MMP3 | P08254 | 6/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | FCER2 | P06734 | 2/20 | 0.52 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 2/20 | 0.49 |
| ▸ | F2R | P25116 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29690852 | 0.94 | LTA4H (0.57) | LTA4HMMEACECPA1ACE2 | |
| SCHEMBL30982345 | 0.88 | MME (0.67) | LTA4HMMEACECPA1ACE2 | |
| SCHEMBL30799925 | 0.88 | LTA4H (0.56) | LTA4HMMEACECPA1ACE2 | |
| SCHEMBL31206426 | 0.86 | MME (0.58) | MMEACECPA1ACE2 | |
| SCHEMBL29525004 | 0.86 | MME (0.61) | MMEACECPA1ACE2 | |
| SCHEMBL11548564 | 0.86 | MME (0.61) | MMEACECPA1ACE2 | |
| SCHEMBL30494635 | 0.86 | MME (0.61) | MMEACECPA1ACE2 | |
| SCHEMBL135366 | 0.86 | MME (0.61) | MMEACECPA1ACE2 | |
| SCHEMBL8761646 | 0.86 | MME (0.61) | MMEACECPA1ACE2 | |
| SCHEMBL668395 | 0.86 | MME (0.61) | MMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022032-A1 | uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | RIGSHOSPITALET (DK) | 2023-01-26 | — | — | US | claimed |
| EP-4081256-A1 | UPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | Rigshospitalet (DK) | 2022-11-02 | — | — | EP | claimed |
| EP-3999094-B1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | RIGSHOSPITALET (DK) | 2026-02-25 | — | — | EP | disclosed |
| US-20230022032-A1 | uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | RIGSHOSPITALET (DK) | 2023-01-26 | — | — | US | disclosed |
| US-20220401585-A1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | RIGSHOSPITALET (DK) | 2022-12-22 | — | — | US | disclosed |
| EP-4081256-A1 | UPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | Rigshospitalet (DK) | 2022-11-02 | — | — | EP | disclosed |
| EP-3999094-A1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | Rigshospitalet (DK) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022032-A1 | uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | PLAUR, PLAU, PLG | LTA4H 264/4885MME 218/4885ACE 1996/4885 |
| US-20220401585-A1 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | PLAUR, PLAU, PLG | LTA4H 1346/4885MME 214/4885ACE 742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.